Related Experiment Videos
Autonomic dependence of ventriculoatrial conduction.
The American Journal of Cardiology
|August 1, 1985
Summary
Isoproterenol and atropine improve ventriculoatrial (VA) conduction in some patients, potentially explaining certain tachycardia types. These autonomic agents enhance atrioventricular node function, facilitating VA conduction.
Area of Science:
- Cardiology
- Electrophysiology
- Autonomic Nervous System
Background:
- Assessing ventriculoatrial (VA) conduction is crucial for understanding supraventricular tachycardias.
- Poor VA conduction can complicate diagnosis and management of cardiac arrhythmias.
Purpose of the Study:
- To evaluate the effects of isoproterenol and atropine on ventriculoatrial (VA) conduction in patients with impaired conduction.
- To determine if these autonomic agents can unmask or improve 1-to-1 VA conduction.
Main Methods:
- Studied two groups of patients based on baseline VA conduction during ventricular pacing.
- Administered isoproterenol infusion and atropine to assess changes in VA conduction intervals and pacing cycle lengths.
- Documented the occurrence of 1-to-1 VA conduction during drug administration.
Main Results:
- Isoproterenol and atropine shortened the pacing cycle lengths that induced VA block in patients with existing 1-to-1 VA conduction.
- Both drugs reduced VA intervals at similar pacing cycle lengths compared to control.
- Nine out of 17 patients with initially poor VA conduction demonstrated 1-to-1 VA conduction after drug administration.
Conclusions:
- Isoproterenol and atropine can improve or reveal 1-to-1 VA conduction, primarily through their effects on the atrioventricular node.
- Autonomic modulation of VA conduction by these drugs may explain the mechanism of certain tachycardias, including endless-loop and paroxysmal supraventricular tachycardia.
- These findings highlight the role of autonomic tone in retrograde atrial activation and tachycardia development.